Advertisement

Management of the Gallbladder Before and After Bariatric Surgery

  • Rohini Khatri
  • Sayeed Ikramuddin
  • Daniel Leslie
Chapter

Abstract

Cholecystectomy is common following bariatric surgery procedures, making the assessment of gallbladder disease a critical component of post-bariatric surgery care. From the standpoint of patient education, there must be an emphasis on adherence to prophylactic therapy, should it be prescribed by the surgeon. For the bariatric surgeon, a conscientious decision must be made regarding the necessity and timing of a cholecystectomy. This chapter will describe the pathophysiology of cholesterol gallstone formation, specifically addressing the unique changes that occur after bariatric surgery; discuss the role of prophylactic cholecystectomy and other management strategies of gallbladder disease; and, finally, address the systems-based challenges in the work-up and management of biliary problems after bariatric surgery.

Keywords

Bariatric Surgery Biliary Tree Ursodeoxycholic Acid Gallbladder Disease Gallstone Formation 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.

References

  1. 1.
    Admirand WH, Small DM. The physicochemical basis of cholesterol gallstone formation in man. J Clin Invest. 1968;47(5):1043–52. doi: 10.1172/JCI105794.PubMedCrossRefPubMedCentralGoogle Scholar
  2. 2.
    Wang HH, Afdhal NH, Wang DQ-H. Estrogen receptor alpha, but not beta, plays a major role in 17beta-estradiol-induced murine cholesterol gallstones. Gastroenterology. 2004;127(1):239–49. Available at: http://www.ncbi.nlm.nih.gov/pubmed/15236189. Accessed 22 May 2013.PubMedCrossRefGoogle Scholar
  3. 3.
    Wang HH, Portincasa P, De Bari O, Liu KJ, Garruti G, Neuschwander-Tetri BA, et al. Prevention of cholesterol gallstones by inhibiting hepatic biosynthesis and intestinal absorption of cholesterol. Eur J Clin Invest. 2013;43(4):413–26. doi: 10.1111/eci.12058. PubMedCrossRefPubMedCentralGoogle Scholar
  4. 4.
    Wang HH, Liu M, Clegg DJ, Portincasa P, Wang DQ-H. New insights into the molecular mechanisms underlying effects of estrogen on cholesterol gallstone formation. Biochim Biophys Acta. 2009;1791(11):1037–47. doi: 10.1016/j.bbalip.2009.06.006.PubMedCrossRefPubMedCentralGoogle Scholar
  5. 5.
    Ozdogan M, Kuvvetli A, Das K, Oruc C, Karateke F, Aydin M, et al. Effect of preserving the hepatic vagal nerve during laparoscopic Nissen fundoplication on postoperative biliary functions. World J Surg. 2013;37(5):1060–4. doi: 10.1007/s00268-013-1958-0.PubMedCrossRefGoogle Scholar
  6. 6.
    Teilum D. The prevalence of gallstones in autopsies from a Danish urban area. Frederiksberg 1914–1955. Acta Chir Scand. 1989;155(2):103–6. Available at: http://www.ncbi.nlm.nih.gov/pubmed/2787087. Accessed 22 May 2013.PubMedGoogle Scholar
  7. 7.
    Schirmer BD, Winters KL, Edlich RF. Cholelithiasis and cholecystitis. J Long Term Eff Med Implants. 2005;15(3):329–38. Available at: http://www.ncbi.nlm.nih.gov/pubmed/16022643. Accessed 22 May 2013.PubMedCrossRefGoogle Scholar
  8. 8.
    Birtwhistle RV, Sauerbrei EE. Ultrasonography in the diagnosis of gallbladder disease. Can Fam Physician. 1983;29:1621–5. Available at: http://www.pubmedcentral.nih.gov/articlerender.fcgi?artid=2153898&tool=pmcentrez&rendertype=abstract. Accessed 26 May 2013.PubMedPubMedCentralGoogle Scholar
  9. 9.
    Guadalajara H, Sanz Baro R, Pascual I, Blesa I, Rotundo GS, López JM, et al. Is prophylactic cholecystectomy useful in obese patients undergoing gastric bypass? Obes Surg. 2006;16(7):883–5. doi: 10.1381/096089206777822287.PubMedCrossRefGoogle Scholar
  10. 10.
    Fobi M, Lee H, Igwe D, Felahy B, James E, Stanczyk M, et al. Prophylactic cholecystectomy with gastric bypass operation: incidence of gallbladder disease. Obes Surg. 2002;12(3):350–3. doi: 10.1381/096089202321088138.PubMedCrossRefGoogle Scholar
  11. 11.
    Torgerson JS, Lindroos AK, Näslund I, Peltonen M. Gallstones, gallbladder disease, and pancreatitis: cross-sectional and 2-year data from the Swedish Obese Subjects (SOS) and SOS reference studies. Am J Gastroenterol. 2003;98(5):1032–41. doi: 10.1111/j.1572-0241.2003.07429.x.PubMedGoogle Scholar
  12. 12.
    Liddle RA, Goldstein RB, Saxton J. Gallstone formation during weight-reduction dieting. Arch Intern Med. 1989;149(8):1750–3. Available at: http://www.ncbi.nlm.nih.gov/pubmed/2669662. Accessed 25 May 2013.PubMedCrossRefGoogle Scholar
  13. 13.
    Miller K, Hell E, Lang B, Lengauer E. Gallstone formation prophylaxis after gastric restrictive procedures for weight loss: a randomized double-blind placebo-controlled trial. Ann Surg. 2003;238(5):697–702. doi: 10.1097/01.sla.0000094305.77843.cf.PubMedCrossRefPubMedCentralGoogle Scholar
  14. 14.
    Erlinger S. Gallstones in obesity and weight loss. Eur J Gastroenterol Hepatol. 2000;12(12):1347–52. Available at: http://www.ncbi.nlm.nih.gov/pubmed/11192327. Accessed 22 May 2013.PubMedCrossRefGoogle Scholar
  15. 15.
    Bastouly M, Arasaki CH, Ferreira JB, Zanoto A, Borges FGHP, Del Grande JC. Early changes in postprandial gallbladder emptying in morbidly obese patients undergoing Roux-en-Y gastric bypass: correlation with the occurrence of biliary sludge and gallstones. Obes Surg. 2009;19(1):22–8. doi: 10.1007/s11695-008-9648-y.PubMedCrossRefGoogle Scholar
  16. 16.
    Ellner SJ, Myers TT, Piorkowski JR, Mavanur AA, Barba CA. Routine cholecystectomy is not mandatory during morbid obesity surgery. Surg Obes Relat Dis. 2007;3(4):456–60. doi: 10.1016/j.soard.2006.11.008.PubMedCrossRefGoogle Scholar
  17. 17.
    Papasavas PK, Gagné DJ, Ceppa FA, Caushaj PF. Routine gallbladder screening not necessary in patients undergoing laparoscopic Roux-en-Y gastric bypass. Surg Obes Relat Dis. 2006;2(1):41–6. doi: 10.1016/j.soard.2005.10.006; discussion 46–7.PubMedCrossRefGoogle Scholar
  18. 18.
    Patel JA, Patel NA, Piper GL, Smith DE, Malhotra G, Colella JJ. Perioperative management of cholelithiasis in patients presenting for laparoscopic Roux-en-Y gastric bypass: have we reached a consensus? Am Surg. 2009;75(6):470–6; discussion 476. Available at: http://www.ncbi.nlm.nih.gov/pubmed/19545094. Accessed 22 May 2013.PubMedGoogle Scholar
  19. 19.
    Patel KR, White SC, Tejirian T, Han SH, Russell D, Vira D, et al. Gallbladder management during laparoscopic Roux-en-Y gastric bypass surgery: routine preoperative screening for gallstones and postoperative prophylactic medical treatment are not necessary. Am Surg. 2006;72(10):857–61. Available at: http://www.ncbi.nlm.nih.gov/pubmed/17058721. Accessed 22 May 2013.PubMedGoogle Scholar
  20. 20.
    Portenier DD, Grant JP, Blackwood HS, Pryor A, McMahon RL, DeMaria E. Expectant management of the asymptomatic gallbladder at Roux-en-Y gastric bypass. Surg Obes Relat Dis. 2007;3(4):476–9. doi: 10.1016/j.soard.2007.02.006.PubMedCrossRefGoogle Scholar
  21. 21.
    Subhas G, Gupta A, Bhullar J, Dubay L, Ferguson L, Goriel Y, et al. Prolonged (longer than 3 hours) laparoscopic cholecystectomy: reasons and results. Am Surg. 2011;77(8):981–4. Available at: http://www.ncbi.nlm.nih.gov/pubmed/21944510. Accessed 22 May 2013.PubMedGoogle Scholar
  22. 22.
    Pavlidis TE, Marakis GN, Ballas K, Symeonidis N, Psarras K, Rafailidis S, et al. Risk factors influencing conversion of laparoscopic to open cholecystectomy. J Laparoendosc Adv Surg Tech A. 2007;17(4):414–8. doi: 10.1089/lap.2006.0178.PubMedCrossRefGoogle Scholar
  23. 23.
    Worni M, Guller U, Shah A, Gandhi M, Shah J, Rajgor D, et al. Cholecystectomy concomitant with laparoscopic gastric bypass: a trend analysis of the nationwide inpatient sample from 2001 to 2008. Obes Surg. 2012;22(2):220–9. doi: 10.1007/s11695-011-0575-y.PubMedCrossRefGoogle Scholar
  24. 24.
    Dorman RB, Zhong W, Abraham AA, Ikramuddin S, Al-Refaie WB, Leslie DB, et al. Does concomitant cholecystectomy at time of Roux-en-Y gastric bypass impact adverse operative outcomes? Obes Surg. 2013;23:1718–26.PubMedCrossRefGoogle Scholar
  25. 25.
    Kothari SN, Obinwanne KM, Baker MT, Mathiason MA, Kallies KJ. A prospective, blinded comparison of laparoscopic ultrasound with transabdominal ultrasound for the detection of gallbladder pathology in morbidly obese patients. J Am Coll Surg. 2013;216(6):1057–62. doi: 10.1016/j.jamcollsurg.2013.02.009.PubMedCrossRefGoogle Scholar
  26. 26.
    Hamad GG, Ikramuddin S, Gourash WF, Schauer PR. Elective cholecystectomy during laparoscopic Roux-en-Y gastric bypass: is it worth the wait? Obes Surg. 2003;13(1):76–81. doi: 10.1381/096089203321136638.PubMedCrossRefGoogle Scholar
  27. 27.
    Sugerman HJ, Brewer WH, Shiffman ML, Brolin RE, Fobi MA, Linner JH, et al. A multicenter, placebo-controlled, randomized, double-blind, prospective trial of prophylactic ursodiol for the prevention of gallstone formation following gastric-bypass-induced rapid weight loss. Am J Surg. 1995;169(1):91–6; discussion 96–7; Available at: http://www.ncbi.nlm.nih.gov/pubmed/7818005. Accessed 22 May 2013.PubMedCrossRefGoogle Scholar
  28. 28.
    Wudel LJ, Wright JK, Debelak JP, Allos TM, Shyr Y, Chapman WC. Prevention of gallstone formation in morbidly obese patients undergoing rapid weight loss: results of a randomized controlled pilot study. J Surg Res. 2002;102(1):50–6. doi: 10.1006/jsre.2001.6322.PubMedCrossRefGoogle Scholar
  29. 29.
    Quesada BM. Management of gallstones and gallbladder disease in patients undergoing gastric bypass. World J Gastroenterol. 2010;16(17):2075. doi: 10.3748/wjg.v16.i17.2075.PubMedCrossRefPubMedCentralGoogle Scholar
  30. 30.
    Taylor J, Leitman IM, Horowitz M. Is routine cholecystectomy necessary at the time of Roux-en-Y gastric bypass? Obes Surg. 2006;16(6):759–61. doi: 10.1381/096089206777346781.PubMedCrossRefGoogle Scholar
  31. 31.
    Tucker ON, Fajnwaks P, Szomstein S, Rosenthal RJ. Is concomitant cholecystectomy necessary in obese patients undergoing laparoscopic gastric bypass surgery? Surg Endosc. 2008;22(11):2450–4. doi: 10.1007/s00464-008-9769-3.PubMedCrossRefGoogle Scholar
  32. 32.
    Benarroch-Gampel J, Lairson DR, Boyd CA, Sheffield KM, Ho V, Riall TS. Cost-effectiveness analysis of cholecystectomy during Roux-en-Y gastric bypass for morbid obesity. Surgery. 2012;152(3):363–75. doi: 10.1016/j.surg.2012.06.013.PubMedCrossRefPubMedCentralGoogle Scholar
  33. 33.
    Attam R, Leslie D, Freeman M, Ikramuddin S, Andrade R. EUS-assisted, fluoroscopically guided gastrostomy tube placement in patients with Roux-en-Y gastric bypass: a novel technique for access to the gastric remnant. Gastrointest Endosc. 2011;74(3):677–82. doi: 10.1016/j.gie.2011.05.018.PubMedCrossRefGoogle Scholar
  34. 34.
    Christou NV, Look D, Maclean LD. Weight gain after short- and long-limb gastric bypass in patients followed for longer than 10 years. Ann Surg. 2006;244(5):734–40. doi: 10.1097/01.sla.0000217592.04061.d5 PubMedCrossRefPubMedCentralGoogle Scholar

Copyright information

© Springer Science+Business Media New York 2015

Authors and Affiliations

  • Rohini Khatri
    • 1
  • Sayeed Ikramuddin
    • 2
  • Daniel Leslie
    • 3
  1. 1.Department of SurgeryUniversity of MinnesotaMinneapolisUSA
  2. 2.Department of SurgeryUniversity of Minnesota Medical SchoolMinneapolisUSA
  3. 3.Division of Gastrointestinal SurgeryUniversity of MinnesotaMinneapolisUSA

Personalised recommendations